retatrutide obesity triple hormone receptor agonist Media Centre Retatrutide: breakthrough… or still too

CrossRef The role of Bergamot Polyphenolic Fraction (BPF) in MASLD-Induced HFpEF: Mitigate diastolic dysfunction by targeting chronic low-grade inflammation Cristina Carresi, Antonio Cardamone, Vincenzo Musolino, Rocco Mollace, Annamaria Tavernese, Anna Rita Coppoletta, Micaela Gliozzi, Vincenzo Mollace Biomedicine & Pharmacotherapy .2025

These victories frequently foreshadow long-term health more than pounds

Both trials suggest maintenance strategies, such as lower-dose injections or oral therapies, could offer patients more flexible, potentially more convenient options for sustaining weight loss after intensive treatment

However, its effects were not sufficient to explain the full incretin response

Constipation is very common and can lead people to stop taking these drugs, and its largely manageable

Some limits are tied to public financing programs or to a limited class of candidates